A healthcare company focused on early cancer detection through its Galleri multi-cancer early detection blood test.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Grail, Inc. in the last 30 days yet.
The 1 sources with the most insights about Grail, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Identified as a key player in the preventative healthcare and multi-cancer early detection market, part of a broader shift toward proactive health management.
Identified as a key player in the preventative healthcare and multi-cancer early detection market, part of a broader shift toward proactive health management.
Other assets that creators frequently mention in the same content as Grail, Inc..
The most active sources covering Grail, Inc. (GRAL) on Kazuha are Harry Stebbings. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Grail, Inc. (GRAL) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Grail, Inc. (GRAL) most frequently also discuss HIMS, NVO. See the "Discussed alongside" section above for full asset pages.